Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

NetSTREIT Corp. Common Stock (NY:NTST)

18.59 -0.16 (-0.85%)
Official Closing Price Updated: 7:00 PM EDT, Aug 5, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about NetSTREIT Corp. Common Stock

< Previous 1 2 3 4 5 Next >
The Next Blockbuster?
Like Blockbuster in the ‘80s and ‘90s, drugstores were the place to be for commercial real estate in the 2000s and early 2010s. 
Via Talk Markets
NETSTREIT Corp. Announces Dates for Second Quarter 2024 Earnings Release and Conference Call
From NETSTREIT Corp.
Via Business Wire
These 3 Real Estate Stocks Delivering High-Dividend Yields Are Recommended By Wall Street's Most Accurate Analysts
 
Via Benzinga
NTST Stock Earnings: Netstreit Beats EPS, Misses Revenue for Q1 2024
NTST stock results show that Netstreit beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. 
Via InvestorPlace
NETSTREIT Reports First Quarter 2024 Financial and Operating Results
From NETSTREIT Corp.
Via Business Wire
Netstreit Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)
 
Via Benzinga
Earnings Scheduled For February 14, 2024
Companies Reporting Before The Bell • Sony Group (NYSE:SONY) is projected to report quarterly earnings at $1.65 per share on revenue of $24.62 billion. 
Via Benzinga
5 Analysts Assess Netstreit: What You Need To Know
 
Via Benzinga
NETSTREIT Corp. Announces Dates for First Quarter 2024 Earnings Release and Conference Call
From NETSTREIT Corp.
Via Business Wire
NETSTREIT Corp. Publishes Its Inaugural Corporate Responsibility Report
From NETSTREIT Corp.
Via Business Wire
NETSTREIT Reports Fourth Quarter and Full Year 2023 Financial and Operating Results
From NETSTREIT Corp.
Via Business Wire
NETSTREIT Corp. Announces Dates for Fourth Quarter and Full Year 2023 Earnings Release and Conference Call
From NETSTREIT Corp.
Via Business Wire
Assessing Netstreit: Insights From 9 Financial Analysts
 
Via Benzinga
Where Netstreit Stands With Analysts
 
Via Benzinga
NETSTREIT Corp. Announces Closing of Forward Common Stock Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
From NETSTREIT Corp.
Via Business Wire
5 Retail REITs With The Best Relative Strength
 
Via Benzinga
NETSTREIT Corp. Announces Launch of Public Offering of Common Stock
From NETSTREIT Corp.
Via Business Wire
NETSTREIT Provides Fourth Quarter and Full Year 2023 Business Update
From NETSTREIT Corp.
Via Business Wire
Truist Securities Maintains Buy Rating for Netstreit: Here's What You Need To Know
 
Via Benzinga
Analyst Expectations for Netstreit's Future
 
Via Benzinga
NETSTREIT Reports Third Quarter 2023 Financial and Operating Results
From NETSTREIT Corp.
Via Business Wire
Earnings Scheduled For October 25, 2023
Companies Reporting Before The Bell • Deutsche Bank (NYSE:DB) is estimated to report quarterly earnings at $0.52 per share on revenue of $7.65 billion. 
Via Benzinga
The Latest Analyst Ratings for Netstreit
 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 19, 2023
 
Via Benzinga
3 REITs Near 52-Week Lows Just Received An Analyst Downgrade
 
Via Benzinga
Rethinking NetSTREIT's Future: KeyBanc Highlights Concerns Over Accretion And FFO Estimates For NTST
KeyBanc Capital Markets analyst Todd M. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 12, 2023
 
Via Benzinga
Top 5 Real Estate Stocks That Could Lead To Your Biggest Gains In Q4
The most oversold stocks in the real estate sector presents an opportunity to buy into undervalued companies. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 10, 2023
 
Via Benzinga
Electronic Arts To Rally Over 20%? Here Are 10 Other Analyst Forecasts For Tuesday
JP Morgan increased ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) price target from $29 to $32. JP Morgan analyst Tessa Romero upgraded the stock from Neutral to Overweight. ACADIA Pharmaceuticals shares... 
Via Benzinga
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.